ToxStrategies Expands Expertise in Regulatory Toxicology
We are pleased to announce the addition of Timothy W. Robison, PhD, DABT, who has 29 years of experience at the US Food… read more
Latest News
ToxStrategies’ scientists publish paper on consumer product exposure to vinyl acetate monomer
ToxStrategies’ scientists Jennifer Bare, Mandie Kramer, and Susan Borghoff are excited share their new paper on consumer product exposure to vinyl acetate monomer… read more
Is it Clean Enough? Reoccupancy After Fires
It is crucial to complete post-fire assessments before a home is reoccupied. ToxStrategies’ team of industrial hygienists are experienced in evaluating homes affected… read more
BlueRidge Life Sciences’ Dr. Naomi Sacks is at ISPOR!
Dr. Naomi Sacks, Vice President, BlueRidge Life Sciences’ Pharmaceutical Commercialization division, is attending the annual meeting of ISPOR (The Professional Society for Health Economics… read more
EpidStrategies Scientists in Collaboration with Duke University and the Central Brain Tumor Registry of the United States are Presenting at the 2025 SNO Pediatric Neuro-Oncology Conference
In the United States, the most common childhood central nervous system cancer is pediatric low-grade glioma, but there are no standardized coding definitions… read more
ToxStrategies will present at The Society of Environmental Toxicology and Chemistry’s (SETAC’s) 35th Annual European Meeting this year, May 12 – 15, in Vienna, Austria.
Dr. Stephanie Kennedy is co-author on three posters regarding risk assessment strategies for microplastics and is looking forward to attending scientific platform and… read more
BlueRidge Life Sciences is at ISPOR 2025 in Montreal!
BlueRidge Life Sciences is at the annual meeting of ISPOR (The Professional Society for Health Economics and Outcomes Research), held this year in… read more
BlueRidge scientist Dr. Naomi Sacks co-authors study ranked in top 10% of most-viewed Obesity Science & Practice articles
BlueRidge Life Sciences Pharmaceutical Commercialization’s Dr. Naomi Sacks’s work published in Obesity Science & Practice on behalf of The Obesity Society was recently… read more
ToxStrategies and EpidStrategies are Pleased to Announce 2025 Staff Promotions
ToxStrategies and EpidStrategies are pleased to announce the promotion of 12 of our scientists, epidemiologists and engineers. We are proud to have them… read more
ToxStrategies’ Dr. William Rish Discusses Cumulative Impact Assessment in New NASEM Workshop Publication
Dr. William Rish, ToxStrategies’ Principal Engineer, was invited to present to an ad hoc committee assembled by the National Academies of Sciences, Engineering,… read more